Bank of America
PDLI

Bank of America’s PDL BioPharma, Inc. PDLI Stock Holding History

Bank of America’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-62,400
Closed -$208K – 7751
2016
Q1 		$208K Sell
62,400
-183,100
-75% -$571K ﹤0.01% 5130
2015
Q4 		$869K Buy
245,500
+65,300
+36% +$273K ﹤0.01% 4457
2015
Q3 		$906K Hold
180,200
– – ﹤0.01% 4395
2015
Q2 		$1.16M Buy
180,200
+30,200
+20% +$202K ﹤0.01% 3972
2015
Q1 		$1.05M Buy
+150,000
New +$1.09M ﹤0.01% 3740
2014
Q4 		– Sell
-240,400
Closed -$1.8M – 8439
2014
Q3 		$1.8M Buy
+240,400
New +$2.23M ﹤0.01% 3488

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.4% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Bank of America's PDLI Position: Q4 2020 in Review

Bank of America sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 38,671 shares — an estimated $122K sold.

Bank of America first reported a position in PDLI in Q2 2013 and held it in 30 quarters. The position peaked at $37.6M in Q4 2014. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Bank of America reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Bank of America sold 38,671 PDL BioPharma, Inc. shares in Q4 2020, an estimated $122K.
  • Bank of America first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 30 quarters.
  • Bank of America's PDL BioPharma, Inc. position peaked at $37.6M in Q4 2014.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Bank of America's 13F filing for Q4 2020, filed 10 Feb 2021.